Literature DB >> 19786749

The microbiota in inflammatory bowel disease in different age groups.

Salvatore Cucchiara1, Valerio Iebba, Maria Pia Conte, Serena Schippa.   

Abstract

BACKGROUND: Many efforts were made in the past decades to assess the role of gut microbiota in inflammatory bowel diseases (IBD), leading to the hypothesis that an altered microbial composition, other than the presence of a specific pathogen, could be involved in the pathogenesis of the disease. On the other hand, existing differences in gut microbial community between distinct classes of age make sense of an increasing research in microbial shifts in IBD.
METHODS: Cultural, molecular, metabolomic and metagenomic approaches are trying to define the human gut microbiota in different age groups. RESULTS AND
CONCLUSION: An increase in anaerobic bacteria (Bacteroidesvulgatus, Streptococcus faecalis) was observed in adult IBD, whereas an increase in aerobic and facultative-anaerobic (Escherichia coli) was found in pediatric IBD. Overall higher bacterial cell counts were observed in IBD, jointly with a general loss of biodiversity and a preponderance of Bacteroidetes and a parallel decrease of Firmicutes phylum: a predominance of potential harmful members of Proteobacteria (E. coli) and low abundance of beneficial species (Faecalibacterium prausnitzii) was also reported in pediatric and adult age groups, respectively. Microbial community of elderly subjects contains a wider range of different species than those of children and adults, both in healthy and IBD status. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19786749     DOI: 10.1159/000228558

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  21 in total

1.  Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities.

Authors:  Roberto Flores; Jianxin Shi; Mitchell H Gail; Jacques Ravel; James J Goedert
Journal:  Eur J Clin Invest       Date:  2012-03-13       Impact factor: 4.686

2.  Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation.

Authors:  Yirui Xie; Zhuanbo Luo; Zhengfeng Li; Min Deng; Hao Liu; Biao Zhu; Bing Ruan; Lanjuan Li
Journal:  Microb Ecol       Date:  2012-03-21       Impact factor: 4.552

3.  High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro.

Authors:  Qing Shen; Lu Zhao; Kieran M Tuohy
Journal:  Eur J Nutr       Date:  2011-09-28       Impact factor: 5.614

4.  Activation of Natural Killer Cells by Probiotics.

Authors:  Nabil Aziz; Benjamin Bonavida
Journal:  For Immunopathol Dis Therap       Date:  2016

5.  How can probiotics and prebiotics impact mucosal immunity?

Authors:  Sarah O'Flaherty; Delphine M Saulnier; Bruno Pot; James Versalovic
Journal:  Gut Microbes       Date:  2010-07-07

Review 6.  Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD.

Authors:  Anita Afzali; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2018-09

7.  Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children.

Authors:  Jing Cheng; Tamar Ringel-Kulka; Ineke Heikamp-de Jong; Yehuda Ringel; Ian Carroll; Willem M de Vos; Jarkko Salojärvi; Reetta Satokari
Journal:  ISME J       Date:  2015-10-02       Impact factor: 10.302

8.  Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth.

Authors:  Mireia Lopez-Siles; Tanweer M Khan; Sylvia H Duncan; Hermie J M Harmsen; L Jesús Garcia-Gil; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2011-11-18       Impact factor: 4.792

9.  Alterations in the gut microbiome of children with severe ulcerative colitis.

Authors:  Sonia Michail; Matthew Durbin; Dan Turner; Anne M Griffiths; David R Mack; Jeffrey Hyams; Neal Leleiko; Harshavardhan Kenche; Adrienne Stolfi; Eytan Wine
Journal:  Inflamm Bowel Dis       Date:  2011-12-14       Impact factor: 5.325

Review 10.  Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative?

Authors:  Christina Ha; Seymour Katz
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.